Pharmaceutical News

RSS

Component in red wine and grapes can suppress inflammation linked to airway disease

A component of red wine and grapes can help control inflammation induced by a bacterial pathogen that is linked to upper respiratory tract inflammatory diseases such as asthma, chronic obstructive pulmonary diseases (COPD) and middle ear infection (otitis media), according to a study by researchers at Georgia State University.

28 Sep 2016

Review highlights potentially toxic effects of herbal and dietary supplements on the liver

A new review based on a research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health highlights the potentially damaging effects of herbal and dietary supplements (HDSs) on the liver.

28 Sep 2016

First generation antibiotics show promise for tuberculosis therapy

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.

28 Sep 2016

Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Toxins from mold found growing on nuts or corn can weaken the airways' self-clearing mechanisms and immunity, opening the door for respiratory diseases and exacerbating existing ones, suggests a study in Nature Scientific Reports published this month from otolaryngology researchers at the Perelman School of Medicine at the University of Pennsylvania.

27 Sep 2016

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.

27 Sep 2016

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.

27 Sep 2016

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.

27 Sep 2016

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide.

26 Sep 2016

High levels of dietary zinc increase susceptibility to Clostridium difficile infections

Too much dietary zinc increases susceptibility to infection by Clostridium difficile - "C. diff" - the most common cause of hospital-acquired infections.

26 Sep 2016

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure.

26 Sep 2016

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The recent approval of pembrolizumab (Keytruda) in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) following progression on a platinum-based chemotherapy was a significant advancement for the disease.

26 Sep 2016

The Lab offers new live resin extract pods designed for PAX Era vaporizer

The Lab, the concentrates production division of The Clinic and one of the leading cannabis extraction companies in Colorado, announced today its first ever live resin extract pods made exclusively for the new Era vaporizer by PAX Labs.

24 Sep 2016

Veracyte announces new data suggesting ability of Afirma GEC in thyroid cancer diagnosis

Veracyte, Inc.today announced new data suggesting the potential to enhance the performance of the Afirma Gene Expression Classifier in thyroid cancer diagnosis by combining the test's proven RNA expression-based capabilities with gene variant and fusion information – all on a single, robust RNA sequencing platform.

24 Sep 2016

Pharmaceutical News

Component in red wine and grapes can suppress inflammation linked to airway disease

Review highlights potentially toxic effects of herbal and dietary supplements on the liver

First generation antibiotics show promise for tuberculosis therapy

Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

Combination of different drugs could improve effect of immunotherapy on skin cancer

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

High levels of dietary zinc increase susceptibility to Clostridium difficile infections

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Approval of PD-1 inhibitor scratches surface of potential immunotherapies in recurrent HNSCC

The Lab offers new live resin extract pods designed for PAX Era vaporizer

Veracyte announces new data suggesting ability of Afirma GEC in thyroid cancer diagnosis

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

National Multiple Sclerosis Society calls for change to make MS drugs accessible

Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine

Antibody drug offers new therapeutic approach for treating AML

Multifunctional nanocapsules could enhance drug delivery to specific disease sites

World leaders at UN meeting commit to develop action plans on antimicrobial resistance

FDA approves new biosimilar for multiple inflammatory diseases

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News